| Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions DA Todd, JJ Kellogg, ED Wallace, M Khin, L Flores-Bocanegra, RS Tanna, ... Scientific reports 10 (1), 19158, 2020 | 84 | 2020 |
| Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants RS Tanna, JT Nguyen, DL Hadi, PK Manwill, L Flores-Bocanegra, ... Pharmaceutics 14 (3), 620, 2022 | 27 | 2022 |
| Refined prediction of pharmacokinetic kratom-drug interactions: time-dependent inhibition considerations RS Tanna, DD Tian, NB Cech, NH Oberlies, AE Rettie, KE Thummel, ... Journal of Pharmacology and Experimental Therapeutics 376 (1), 64-73, 2021 | 25 | 2021 |
| Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail JT Nguyen, DD Tian, RS Tanna, DL Hadi, S Bansal, JC Calamia, ... Clinical Pharmacology & Therapeutics 109 (5), 1342-1352, 2021 | 24 | 2021 |
| Clinical assessment of the drug interaction potential of the psychotropic natural product kratom RS Tanna, JT Nguyen, DL Hadi, ME Layton, JR White, NB Cech, ... Clinical Pharmacology & Therapeutics 113 (6), 1315-1325, 2023 | 9 | 2023 |
| Translating kratom-drug interactions: from bedside to bench and back RS Tanna, NB Cech, NH Oberlies, AE Rettie, KE Thummel, MF Paine Drug Metabolism and Disposition 51 (8), 923-935, 2023 | 7 | 2023 |
| Determining mechanisms underlying the goldenseal‐midazolam interaction in humans using an in vitro to in vivo extrapolation approach RS Tanna, DD Tian, MG McDonald, J Calamia, AE Rettie, KE Thummel, ... The FASEB Journal 33 (S1), 814.14-814.14, 2019 | 2 | 2019 |
| An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based … JT Nguyen, DD Tian, RS Tanna, CM Arian, JC Calamia, AE Rettie, ... Journal of Pharmacology and Experimental Therapeutics 387 (3), 252-264, 2023 | 1 | 2023 |
| Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants JD Clarke, SM Judson, DD Tian, TO Kirby, RS Tanna, A Matula‐Péntek, ... Clinical and Translational Science 16 (10), 1779-1790, 2023 | 1 | 2023 |
| INFLUENCE OF TRANSPORTERS AND THE GUT MICROBIOTA ON THE PHARMACOKINETIC GREEN TEA-RALOXIFENE INTERACTION. S Judson, M Paine, T Kirby, R Tanna, E Gallagher, A Matula-Péntek, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S71-S71, 2020 | 1 | 2020 |
| P123-Assessing the predictive performance of in silico generated binding parameters for various natural product constituents J Nguyen, D Tian, R Tanna, M Paine Drug Metabolism and Pharmacokinetics 35 (1), S60, 2020 | 1 | 2020 |
| Assessing the pharmacokinetic drug interaction potential of kratom with drugs of abuse RS Tanna Washington State University, 2023 | | 2023 |
| ASSESSING TRANSPORTER-MEDIATED NATURAL PRODUCT-DRUG INTERACTIONS USING A COCKTAIL APPROACH. J Nguyen, R Tanna, D Tian, S Bansal, B Molnar, M Horvath, J Kellogg, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S61-S62, 2020 | | 2020 |
| P83-The natural product kratom is a potential precipitant of pharmacokinetic interactions with common drugs of abuse R Tanna, DD Tian, J Nguyen, N Cech, N Oberlies, M Paine Drug Metabolism and Pharmacokinetics 35 (1), S47, 2020 | | 2020 |
